Stay updated on ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    No significant changes were detected; the study arms, outcomes, eligibility, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:08:45.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and funding-related limitations are added, plus a version bump to v3.2.0; previous v3.1.0 deletion indicates a version upgrade.
    Difference
    3%
    Check dated 2025-10-06T05:30:54.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T03:03:37.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2, signaling a new release with fixes or improvements. The 'Back to Top' link/control was removed, a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-14T19:13:42.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T15:31:45.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as detailed information on various cancer-related topics and medical compounds. Notably, the previous version's location details have been replaced with more specific entries.
    Difference
    7%
    Check dated 2025-08-31T11:54:31.000Z thumbnail image

Stay in the know with updates to ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.